CLEVELAND, June 5, 2017 – Nature Communications has published the research of Daniel I. Simon, M.D.; Edward Plow, Ph.D.; and Yunmei Wang, Ph.D. – Founders of Sujana Biotech – which describes a novel target for thrombotic disorders that does not effect hemostasis (bleeding time)

Read full Nature Communications article here

Read full press release here